4547 — Kissei Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00
- ¥159bn
- ¥118bn
- ¥67bn
- 49
- 53
- 93
- 77
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 72,297 | 63,234 | 69,044 | 65,381 | 67,493 |
Cost of Revenue | |||||
Gross Profit | 45,562 | 34,894 | 32,723 | 31,238 | 32,375 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 66,321 | 62,179 | 66,893 | 67,223 | 68,556 |
Operating Profit | 5,976 | 1,055 | 2,151 | -1,842 | -1,063 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,121 | 4,630 | 7,476 | 16,507 | 13,680 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,535 | 2,889 | 5,378 | 13,032 | 10,634 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5,481 | 2,818 | 5,285 | 12,922 | 10,529 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,481 | 2,817 | 5,285 | 12,921 | 10,528 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 121 | 71.5 | 103 | 288 | 226 |
Dividends per Share |